Third Party Pharma Manufacturing in India

Vibcare Healthcare is a compliance-led pharmaceutical contract manufacturing partner for brand owners and pharma marketing companies. We manufacture Tablets, Capsules, Oral Liquids, and External preparations with structured quality systems, documentation discipline, and scalable execution.

Manufacturing Capabilities and Dosage Form

We manufacture multiple dosage forms under structured quality systems. Below is a quick snapshot of our capabilities and indicative annual capacity by section.

Tablets

High-volume tablets with consistent batch quality.

ANNUAL CAPACITY

3.5 Billion

Capsules

Repeatable batches with controlled QC release.

ANNUAL CAPACITY

1.2 Billion

Oral Liquids

Stability-first manufacturing controls.

ANNUAL CAPACITY

80 Million

Externals / Ointments

Creams & ointments with uniformity.

ANNUAL CAPACITY

25 Million

Why Choose Vibcare Healthcare?

When you outsource third-party pharma manufacturing, the real risks are delays, inconsistent batches, weak documentation, and unclear accountability. Vibcare Healthcare is built to reduce those risks with compliance-led operations, clear communication, and scalable production.

Faster Turnaround Times

Lean planning and controlled workflows reduce avoidable delays—so your launches and replenishments stay on track.

Market-Ready Packaging

Modern packaging options with clean execution—helping your brand look credible, consistent, and shelf-ready.

Rigorous Quality Control

Every batch passes through stringent in-process and post-process QC testing in our fully equipped labs.

Documentation You Can Defend

Clear batch documentation and COA-aligned release support—built for brands that care about audits and credibility.

Scalable Capacity, Flexible MOQs

From smaller initial runs to high-volume repeat production—your growth doesn’t require changing manufacturers.

Transparent Partnership

No vague commitments. Clear communication, ethical practices, and defined responsibilities from RFQ to dispatch.

What Is Third Party Manufacturing?

Third party manufacturing (also called pharmaceutical contract manufacturing) is a business model where a brand owner or pharma marketing company gets medicines manufactured at a licensed, compliant facility—under an agreed scope, specifications, and quality responsibilities.

In simple terms: You own the brand and market access; we manufacture under a controlled quality system and support documentation and packaging execution as per the agreed requirements.

Who typically uses third party pharma manufacturing?

Why brands choose it

How It Works (Process / Timeline)

A clean contract manufacturing engagement succeeds when responsibilities are defined early and execution is structured. Here is the typical flow we follow:

Phase 1: Planning & Feasibility

01
Requirement Capture (Day 0–1)

You share basics: Dosage form, Composition, Packaging format, and Target volumes.

02
Feasibility Review (Day 1–3)

We evaluate manufacturing fit, packaging stability, timeline assumptions, and documentation scope.

03
Quotation + Alignment (Day 2–5)

You receive a structured proposal with pricing, lead times, and a next-step checklist to avoid delays.

04
Documentation & Artwork (Week 1)

We align on master specifications, artwork/label inputs, and final production plans. (NDA stage).

Phase 2: Execution & Delivery

05
Planning + Procurement (Week 1–2)

We lock the production slot, batch plan, material/pack readiness, and quality checkpoints.

06
Manufacturing (Week 2–4)

Production executed with in-process checks and controlled documentation for consistency.

07
QC Testing + Release (Week 3–5)

QC testing aligned with agreed scope (COA) so dispatch isn’t delayed by gaps.

08
Packing + Dispatch (Week 4–6)

Final packing, dispatch coordination, and post-dispatch support for planning.

Note: Timelines vary by dosage form, packaging complexity, batch size, and readiness of inputs.

Frequently Asked Questions

Everything you need to know about our third-party manufacturing process.

In pharma, the terms are often used interchangeably. In a strict compliance sense, it’s about a documented agreement and defined responsibilities for manufacturing/testing and quality events.

Yes. For serious projects, NDA-first is recommended before exchanging sensitive formulations, vendor details, or commercial inputs.

Tablets, Capsules, Oral Liquids, and External preparations (creams/ointments, etc.).

Yes—packaging coordination is part of execution, aligned to your product requirement and positioning.

Typical outputs include batch-related documentation and QC outputs as applicable (e.g., COA format), aligned to GMP documentation expectations.

MOQ depends on dosage form, pack style, and batch planning. Share your target pack and forecast; we’ll confirm feasibility.

GMP emphasizes defined and documented processes for production and testing and suitability of personnel/premises/materials. Our execution is designed around that discipline.

We support compliance discussions and audit-readiness pathways appropriate for contract manufacturing relationships (scope defined case-by-case).

Yes—dispatch planning can be aligned to your distribution model.

Yes—third party manufacturing is commonly executed for marketer/brand-owner labeling requirements, within the compliant framework.

We can guide whether your requirement fits standard contract manufacturing or needs a development-oriented CDMO approach. (A dedicated CDMO page is recommended for this topic.)

Use the RFQ form. Share dosage form, composition/strengths, packaging preference, and your target volumes.